Complications Flashcards
What are the Marco and Microvascular complications
Micro
- retinopathy
-nephropathy
-neuropathy
Macro
- cerebrovascular disease and stroke
- CAD/CVD, MI risk
- PVD, wounds, amputations
Mild vs moderate vs severe hypoglycaemia
Mild - autonomic (neurogenic) symptoms present, individual can self treat
Moderate- autonomic and neuroglycopenic symptoms present, individual is able to self treat
Severe - individual cannot self treat (PG usually <2.8mmol/L)
Define hypoglycaemia
1.) autonomic and/or neuroglycopenic symptoms
2.) low plasma glucose (<4 for those with diabetes on insulin or taking sulfonylureas or miglitinides
3.) symptoms respond to the administration of carbohydrate.
The severity of hyperglycaemia is defined by clinical manifestations
Risk factors for severe hypoglycemia in people treated with sulfonylureas or insulin
-Prior episode of severe hypoglycemia
-Current low AIC (<6.0%)
-Hypoglycemia unawareness
-Long duration of insulin therapy
-Autonomic neuropathy
-Chronic kidney disease
- Low economic status, food insecurity
- Low health literacy
- Preschool-aged children unable to detect and /or treat mild hypoglycemia on their own
- Adolescence
- Pregnancy
- Elderly
- Cognitive impairment
DKA treatment
Insulin infusion @ 1 unit/kg/hr
Bicarbonate therapy for extreme acidosis (ph <7)
DKA might happen at normal or mildly elevated BG in which cases?
Pregnancy
Those taking SGLT2 inhibitors
Screening for CKD in T1DM vs T2DM
T1 - 5 years after Dx
T2 - at time of Dx
Risk factors for Neuropathy
Hyperglycaemia
High triglycerides
High BMI
Smoking
HTN
Most common form of diabetic neuropathy
Distal symmetric polyneuropathy (DSPN)
gradual loss of integrity of the longest nerve fibers, with symptoms beginning distally and symmetrically in the small muscle fibres in toes and feet.
Small fibres - burning, sharp, shooting pain
Large fibres - numbness, tingling, loss of protective sensation
If the 10g stemmes-weinstein monofilament test was used, what is the threshold for neuropathy Dx?
A score of 3/8 = neuropathy is likely present
3.5-5 = risk of new onset neuropathy in the next 4 years is high
5.5 + = risk of new onset neuropathy in the next 4 years is low